Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced that its management team is scheduled to ...

Iambic Therapeutics, a clinical-stage life science and technology company developing novel medicines using its AI-driven discovery and development platform, today announced its participation in the ...

SB 3 is expected to receive final approval in the House on Thursday before returning to the Senate. Senate lawmakers will ...

A new review warns healthcare professionals about the potential dermatological risks of cannabis use, from allergic reactions ...

Dr. Tomáš Páleníček is a leading Czech proponent of the use of psychedelics in certain kinds of psychiatric treatment. Such ...

The controversial measure is one of the top priorities of the 2025 legislative session for Lt. Gov. Dan Patrick.

The obesity market has garnered much interest lately, propelled by the success of GLP-1 therapies Wegovy and Zepbound, marketed by pharma giants Novo Nordisk NVO and Eli Lilly LLY, respectively. This ...

Dr. Tomáš Páleníček is a leading Czech proponent of the use of psychedelics in certain kinds of psychiatric treatment. Such research has history in this part of the world.

A new study published in BMC Genomics explores how different parts of the marijuana plant influence the production of ...

POTOMAC, MD / ACCESS Newswire / May 22, 2025 / IGC Pharma, Inc. ("IGC", or the "Company") (NYSE American:IGC) today announced a clinical trial site at Santa Cruz Behavioral in Puerto Rico for its CALM ...